MENU
THAR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tharimmune (THAR) Ownership - Who owns Tharimmune?
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases... Show more
Profile
Industry
N/A
Address
1200 Route 22 East
Phone
+1 908 955-3140
Employees
3
Web
https://www.hillstreambio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.32M
P/E Ratio
0.02
Total Cash
4.77M
Projected Growth
N/A
Total Debt
559.92K
Revenue
N/A
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
2.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
THAR
Capitalization
2.32M
P/E Ratio
0.02
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
4.77M
Total Cash/Share
2.26
Total Debt
560K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.02M
P/B Ratio
1.77
Cash Flow
N/A
Earnings
61.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
129
Current Ratio
2.35
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.84M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-257.79
Shares Held By Institutions
317K
Shares Outstanding - Current
2.11M
Total Liabilities
2.23M
Total Volume MTD
N/A
Value
1
Gain YTD
-45.813
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1200 Route 22 East
Phone
+1 908 955-3140
Employees
3
Web
https://www.hillstreambio.com